Jun 5, 2026 | Announcements, Compliance, Consolidated Appropriations Act of 2021 (CAA), Pharmacy, Regulatory
As you may recall, the Consolidated Appropriations Act of 2021 (CAA) requires all health plans to file a pharmacy data report annually with the Centers for Medicare & Medicaid Services (CMS). For the 2025 reporting cycle, the Prescription Drug Data Collection...
Apr 20, 2026 | Alternative Reimbursement Strategies, Client Report, Compliance, MedBen Access, MedBen Employees, MedBen News, MedBen University, Pharmacy, Regulatory, Spending, Wellness
MedBen had a full house of employers and brokers in attendance at MedBen University’s (MBU) 25th annual Employer Roundtable on April 16 at the C. Arthur Morrow Conference Center in Newark, Ohio. Presented by MedBen’s team of industry experts, this year’s roundtable...
Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Feb 9, 2026 | Discounts, News, Online Services, Pharmacy, TrumpRx
The February 5th launch of the TrumpRx.gov online portal has generated attention for its lower prescription drug pricing… and may offer value for self-funded pharmacy plans in cases where medications are excluded from coverage or members face high upfront costs. While...
Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Dec 29, 2025 | MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Transparency
While the major PBMs still dominate the market, their grip is loosening. A recent Pulse of the Purchaser survey found that the percentage of employers contracted with one of the Big 3 dropped from 72% in 2024 to 61% by late 2025, as more organizations shifted toward...
